中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Issue 8
Aug.  2014
Turn off MathJax
Article Contents

The role of intestinal endotoxemia in liver failure and its complications

DOI: 10.3969/j.issn.1001-5256.2014.08.036
Research funding:

 

  • Received Date: 2013-11-04
  • Published Date: 2014-08-20
  • Recent studies have found that endotoxin not only activates immune response, exacerbates liver injury, and induces liver failure, but also plays an important role in the development of hepatic encephalopathy, hepatorenal syndrome, spontaneous bacterial peritonitis, and other fatal complications.The recent progress in research on the pathogenesis of intestinal endotoxemia (IETM) and its impact on the development and progression of liver failure is reviewed and summarized.It is suggested that seeking effective methods to prevent and control IETM holds promise as the key to treating severe liver disease and liver failure successfully.

     

  • loading
  • [1]BAUER TM, SCHWACHA H, STEINBRCKNER B, et al.Small intestinal overgrowth and bacterial translocation in human cirrhosis is associated with systemic endotoxinemia[J].Am J Gastroenterol, 2002, 97 (9) :2364-2370.
    [2] CHANG CS, CHEN GH, LIEN HC, et al.Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis[J].Hepatology, 1998, 28 (5) :1187-1190.
    [3]BILZER M, ROGGEL F, GERBES AL.Role of Kupffer cells in host defense and liver disease[J].Liver Int, 2006, 26 (10) :1175-1186.
    [4]SU GL.Lipopolysaccharides in liver injury:molecular mechanisms of Kupffer cell activation[J].Am J Physiol Gastrointest Liver Physiol, 2002, 283 (2) :g256-g265.
    [5]VERBEKE L, NEVENS F, LALEMAN W.Bench-to-beside review:Acute-on-chronic liver failure-linking the gut, liver and systemic circulation[J].Critical Care, 2011, 15 (5) :233-243.
    [6]ZHANG HY, HAN DW, WANG XG, et al.Experimental study on the role of endotoxin in the development of hepatopulmonary syndrome[J].World J Gastroenterol, 2005, 11 (4) :567-572.
    [7] SEKI E, BRENNER DA.Toll-like receptors and adaptor molecules in liver disease:update[J].Hepatology, 2008, 48 (1) :322-335.
    [8]ANTONIADES CG, BERRY PA, WENDON JA, et al.The importance of immune dysfunction in determining outcome in acute liver failure[J].J Hepatol, 2008, 49 (5) :845-861.
    [9]NOTAS G, KISSELEVA T, BRENNER D.NK and NKT cells in liver injury and fibrosis[J].Clin Immunol, 2009, 130 (1) :16-26.
    [10]STEINHOFF G, BEHREND M, SCHRADER B, et al.Expression patterns of leukocyte adhesion ligand molecules on human liver endothelia.Lack of ELAM-1 and CD62 inducibility on sinusoidal endothelia and distinct distribution of VCAM-1, ICAM-1, ICAM-2 and LFA-3[J].Am J Pathol, 1993, 142 (2) :481-488.
    [11]ROCKEY DC, FOUASSIER L, CHUNG JJ, et al.Cellular localization of endothelin-1 and increased production in liver injury in the rat:potential for autocrine and paracrine effects on stellate cells[J].Hepatology, 1998, 27 (2) :472-480.
    [12]HAN DW.Intestinal endotoxemia as a pathogenetic mechanism in liver failure[J].World J Gastroenterol, 2002, 8 (6) :961-965.
    [13]LI JF, DUAN ZP.Acute-on-chronic liver failure:from pathophysiology to clinical practice[J].J Clin Hepatol, 2013, 29 (9) :641-644. (in Chinese) 李俊峰, 段钟平.慢加急性肝衰竭:从病理生理到临床实践[J].临床肝胆病杂志, 2013, 29 (9) :641-644.
    [14]FERENCI P, LOCKWOOD A, MULLEN K, et al.Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification:final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998[J].Hepatology, 2002, 35 (3) :716-721.
    [15]SHAWCROSS DL, WRIGHT G, OLDE DAMINK SW, et al.Role of ammonia and inflammation in minimal hepatic encephalopathy[J].Metab Brain Dis, 2007, 22 (1) :125-138.
    [16]SHARIFI Y, YEOMAN A, AUSTIN M, et al.Defining the outcomes of severe hepatic encephalopathy in cirrhosis:inflammation is the key[J].Hepatology, 2008, 48 (Suppl) :1061A.
    [17]LICINIO J, WONG ML.Pathways and mechanisms for cytokine signaling of the central nervous system[J].J Clin Invest, 1997, 100 (12) :2941-2947.
    [18]SHAWCROSS DL, SHARIFI Y, CANAVAN JB, et al.Infection and systemic inflammation, not ammonia, are associated with Grade3/4 hepatic encephalopathy, but not mortality in cirrhosis[J].J Hepatol, 2011, 54 (4) :640-649.
    [19]BELLOT P, FRANCSR, SUCH J.Pathological bacterial translocation in cirrhosis:pathophysiology, diagnosis and clinical implications[J].Liver Int, 2013, 33 (1) :31-39.
    [20]MOORE K.The hepatorenal syndrome[J].Clin Sci (Lond) , 1997, 92 (5) :433-443.
    [21]MAZUR JE, COOPER TB, DASTA JF.Terlipressin in hepatorenal syndrome[J].Ann Pharmacoter, 2011, 45 (3) :380-387.
    [22]KAYALI Z, HERRING J, BARON P, et al.Increased plasma nitric oxide, L-arginine, and arginase-1 in cirrhotic patients with progressive renal dysfunction[J].J Gastroenterol Hepatol, 2009, 24 (6) :1030-1037.
    [23] WEERATEERANGKUL P, CHATTIPAKORN S, CHATTIPAKORN N.Roles of the nitric oxide signaling pathway in cardiac ischemic preconditioning against myocardial ischemia-reperfusion injury[J].Med Sci Monit, 2011, 17 (2) :RA44-52.
    [24]GARCIA-TSAO G.Bacterial translocation:cause or consequence of decompensation in cirrhosis?[J].J Hepatol, 2001, 34 (1) :150-155.
    [25]DIAL EJ, TRAN DM, HYMAN A, et al.Endotoxin-induced changes in phospholipid dynamics of the stomach[J].J Surg Res, 2013, 180 (1) :140-146.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2629) PDF downloads(505) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return